Furthermore, among those expressing SSTR2, there was a trend of higher expression of SSTR2 (≥ 50%) in thymic carcinomas (10 of 19, 52.6%) and TNETs (2 of 4, 50%) than in thymomas (0 of 6) (p=0.07) (Table 2). Here, SSTR2 is linked to thymic carcinoma.